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Abstract:
Lung cancer is one of the most fatal diseases in the world, so it is important to
understand the pattern of lung cancer trends at population level. The
age-period-cohort model (APC model) is used in this article to analyze the effects of
age, year at diagnosis and year at birth on lung cancer in the U.S. The results suggest
the age, period and cohort curvature effects are all significant on the lung cancer
incidence and mortality. By looking at the plot of the age, period and cohort effects,
we found historical events of interest like world war, sales strategies by tobacco
companies and lung cancer screening technology may drive the period and cohort
effects on the lung cancer in the U.S. The methodology used in this paper will be
helpful for public health interventions evaluation and predicting the outcomes the
future disease fluctuation driven by those interventions.
Introduction:
The death rates of lung and bronchus cancer is much higher than other cancer in
2015, so it is critical to analyze the lung cancer trends at a population level and
evaluate the effects of public interventions. The trends of lung cancer incidence and
mortality rates provides important clues for its etiology. The temporal factors in lung
cancer trend analysis include: (i) age at diagnosis; (ii) period, which is year at
diagnosis; (iii) cohort, which is the year of birth. The period effect on lung cancer
could result from the date of the event of interest, such as changes in lung cancer
screening. On the other hand, the cohort effects on lung cancer may reveal
generational exposures, which could be the change of smoking habits by promotional
activities that influenced people at a young age. A classic example of the generational
exposure is the distribution of free cigarettes to military recruits during the World War
II. Also, during 1960s and 1970s, women in the United States were strongly targeted
by tobacco companies, which was suggested as a manifestation of women’s rights[1].
APC models estimate the age, period and cohort effects in a generalize linear
model and provide an interpretation of the temporal trends for lung cancer incidence
rate and mortality rates. The APC model suffers from the identifiability problem
because of the linear dependence between the age, period and cohort, which is cohort
= period - age. To overcome the identifiability problem, a potential solution is to
partition the age, period and cohort effects into the overall linear trend and the
corresponding curvature (the deviation from the linear trend) and to set arbitrary
constraints on the parameters. It is commonly known that curvature of the age, period
and cohort effects are estimable regardless the constraint that is applied. The curvature
effects of age, period and cohort are helpful for detection of major fluctuations around
the general linear trends.
The disease data is tabulated into a form that divides age and period into the
corresponding intervals. This analysis uses equal age and period interval widths.
However, for research purpose sometimes the interval widths of age and period may
not be equal, which may bring another identifiability problem. The additional
identifiability problem usually results in saw-toothed micro-trend, which is
biologically implausible.
In this paper, the age, period and cohort effects on lung cancer incidence and
mortality rates will be analyzed by the APC model and the smoothing spline function
will be used to solve the micro-identifiability problem due to the unequal age and
period interval widths[2].
Methods:
The data of interest is lung cancer incidence and mortality in the cancer registry
of Surveillance Epidemiology and End Results (SEER) Program
(www.seer.cancer.gov) and the vital statistics in the U.S from the National Bureau of
Economic
Research(http://www.nber.org/data/vital-statistics-mortality-data-multiple-cause-of-de
ath.html). The population of interest is people aged 35 to 84 who were diagnosed with
lung cancer between 1973 to 2014. In SEER, lung cancer is defined as diagnosis of
malignant neoplasms of trachea, bronchus and lung while the lung cancer mortality is
defined as the SEER specific-cause of death. In data tabulation for the overall lung
cancer trend, the age is divided into 5-year intervals while year is a single-year
interval, for a better visualization of the trend. For the APC model fitting, we employ
single age intervals with age index i (i=1,2,3, ...85), for period j (j = 1973,
1974,...2014) and for cohort k = j-i The response variables are ijkijkijk pn /

,
where the ijkn represents the lung cancer incidence or lung cancer mortality in SEER
and the U.S with a Poisson distribution and ijkp represents the population
corresponding to the lung cancer incidence and mortality.
The format of the APC model on lung cancer is:
kjiijk  )(
)( ijk is the link function, i.e., the log function,  is the intercept, i is the age
effect, j is the period effect and k is the cohort effect. To avoid adding
constraints, we could partition the effects into linear trend and curvature trends. For
example, for age effects: Ciii    * , where i* is the normalized index for age
( 2/)1(*  Iii ). Similarly, we have the curvature effects for period and cohort as
well. The format of APC model will be:
CkCjCikjiijk kji    ***)(
One way to obtain curvature is by using the orthogonal method, where the set of
regressors can be found by making the analysis-of-variance design matrix that
orthogonal to the linear term. Meanwhile, the linear period trends are forced to be
zero, with the slopes of age and cohort added to the curvature terms. In this way, the
estimates of slopes become the estimate (    ) for age and (    ) for cohort.
To obtain the curvature effects, the response variables are the lung cancer incidence
and lung cancer death rate in SEER and the U.S, with the period slope (?) variable
excluded in the model[1].
On the other hand, the smoothing spline function is applied to solve the micro-trend
identifiability problem because it puts a reduction in the magnitude of the serrated
pattern which can have arbitrarily large amplitude, which depends on the constraint
used to find a set of parameter estimates. In the analysis, the knots are set depending
on the interval width of age, period and cohort. The number of knots for the age spline
function are set as 5, which are: 40, 50, 60, 70 and 80. The number of knots for period
spline function are set as 7, which are: 1980, 1985, 1990, 1995, 2000, 2005 and 2010.
The number of knots for cohort spline function are set as 8, which are: 1900, 1910,
1920, 1930, 1940, 1950, 1960 and 1970[2].
Also, the lung cancer incidence and mortality in the U.S are plotted by period and
cohort with different age group, which provides an overview of the trend of lung
cancer incidence and mortality.
The model comparison is used to test the significance of the curvature effects of
age, period and cohort. The reduced models will be an APC model without age,
period and cohort curvature effects individually and null hypothesis is that there is no
difference between full model (with age, period and cohort model) and reduced
model.
Result:
1. Lung cancer mortality trend
The lung cancer mortality trend shows that people with higher age have
increasing lung cancer mortality rate in both SEER lung cancer registry and the U.S.
By looking at the mortality trend by period, the lung cancer mortality in different age
groups are relatively steady in the SEER cancer registry compared to those in the U.S
population. In detail, people who are older than 70 have their lung cancer mortality
increased during the year at diagnosis in the U.S population, while the rest reached
peaks around 1995 (Figure.1). Lung cancer mortality trend was also analyzed in
different by sex. For females, the both SEER and U.S population shows a similar
pattern to the overall trend (Figure.2.). In contrast, the lung cancer mortality rate in
males increased by period until 1990 then decreased (Figure.3.).
In contrast, the overall lung cancer mortality rate peaked for people born
1920-1930 in SEER and U.S population among different age group. For females, the
pattern of lung cancer mortality rates among cohorts is similar to the one in overall
lung cancer mortality rate trend (Figure.5.). However, people born around 1910 had
the highest lung cancer mortality rate (Figure.6.).
Overall, the lung cancer mortality rate is much higher in males compare to
females.
Figure.1. The crude lung cancer mortality trend by year in SEER lung cancer registry and the U.S
Figure.2. The lung cancer mortality trend in female by period in SEER lung cancer registry and
the U.S
Figure.3. The lung cancer mortality trend in female by period in SEER lung cancer registry and
the U.S
Figure.4. The lung cancer mortality trend by cohort in SEER lung cancer registry and the U.S
Figure.5. The lung cancer mortality trend in female by cohort in SEER lung cancer registry and the
U.S
Figure.6. The lung cancer mortality trend in male by cohort in SEER lung cancer registry and the
U.S
2. Temporal curvature effects on lung cancer on incidence and mortality.
The curvature effects of age, period and cohort were calculated from the full
model and spline function. These linear predictors are plotted on a graph and analyzed
for their impact on the linear trend of age, period and cohort. For the crude curvature
effects of age on lung cancer incidence in SEER registries, Figure.7 suggests that the
crude age effect decreases in negative departure direction for people who were
younger than 55 years old. However, the crude curvature effects increase for people
aged more than 55 years and peaks around 75 years and remains at a similar level
thereafter. The age curvature effects on lung cancer incidence in SEER lung cancer
registries are analyzed as well. Figure 8 shows that the age curvature effects on lung
cancer incidence is similar between male and female in SEER cancer registries. The
female group shows a higher extent of positive curvature effects of age than male.
Similar patterns are observed for age curvature effects on lung cancer mortality in
SEER registries and the U.S.
For period effects, Figure 9 shows that crude period curvature effect on SEER
lung cancer incidence decreases in negative departure direction until 1980. However,
it increases subsequently reaching peaks around 1985. After 1985, the period effect
decreases again along the year at diagnosis and reaches the lowest level around 2000,
Then the period effect again rises started to have increasing rate in the decreasing
direction and becomes relatively constant. According to Figure 10, both males and
females in SEER cancer registries have curvature effects of period that decreases
before 1980. Then, their curvature effects increase reaching peaks around 1985 for
males and 1990 for females. Then the curvature effects decrease. For males, the
curvature effects decrease and reach a valley around 2000 after which it increases
slightly. In contrast, the curvature effects for female decreases after 2000. In contrast,
the pattern of period curvature effects on lung cancer mortality is quite different. In
detail, Figure 15 shows that curvature effects of period on lung cancer mortality in
SEER registries decreases from 1973 to 1980 (negative departure) but increases in
adverse direction after 1980 and peaked around 1990 and 2005, which is different
from the pattern of period curvature effects on lung cancer incidence. Then, the period
curvature increases in negative departure direction after 2008. Compared to the crude
effects, the curvature effects of period in male and female shows similar pattern. The
difference is that the extent of curvature period effect in female is lower than male
before 1980 and after 2007 but remains higher in the rest of time (Figure 16.).
The crude curvature effects of period on mortality shows similar pattern to those
effects on the lung cancer incidence, where a concave shape could be observed.
Specifically, the period effect declines from 1973 to 1980 and from 1990 to 2005. The
period effect increases from 1980 to 1990 and from 2005 to 2014. This curvature
effect peaks around 1990 (Figure 21.). The curvature effect of period on the lung
cancer mortality in the U.S for male and female shows similar pattern compare to the
crude period effects. However, the extent of the curvature period effects is higher in
females than males (Figure 22.).
The crude cohort effect in Figure.11 shows that the departure from the cohort
linear trend peaks around 1930 and the cohort effect decreases along the year of birth
finally have increasingly negative departure on the cohort linear trend after 1950
(Figure 11.). Looking by sex, the curvature effects of year of birth on males remain
relatively positive until 1920, when the effect starts to decrease. For females, however,
the curvature effects decrease in negative departure direction but increases in positive
departure direction and finally peaks around 1940 and had 2nd peak around 1960.
Then, the departure of cohort starts to decline after 1960. (Figure 12.). Compare to the
curvature effects on incidence, Figure 17 suggests that the cohort curvature effects on
SEER lung cancer mortality increases since 1900 on positive departure direction and
peaks around 1930. Then it declines until 1950. Then, it increases in negative
departure direction. More specifically, Figure 18 shows that the cohort curvature
effects on SEER lung cancer mortality shows similar patterns compare to these effects
on lung cancer incidence for male and female. The crude curvature effects of cohort
on lung cancer mortality in the U.S peaks around 1930 and then the departure
decreases until 1950. Then the cohort effect had adverse effects and constantly
increase since 1950 (Figure 23.). If look at the difference of cohort effects by sex,the
cohort curvature effects on the lung cancer mortality in male follows the crude
curvature effects. On the other hand, the curvature cohort effects on female decreases
in negative direction but increases after 1910, and peaks around 1940 and 1960. After
1970, the cohort curvature again decreases and back to the negative direction (Figure
24.).
Figure 7. The crude a effects on lung cancer incidence in SEER registries.
Figure 8. Age effects on lung cancer incidence for male and female in SEER registries.
Figure 9. Period effects on lung cancer incidence in SEER lung cancer registries.
Figure 10. Period effects on lung cancer incidence in SEER lung cancer registries
Figure 11. Cohort effects on lung cancer incidence in SEER registries
Figure 12. The cohort effects on lung cancer incidence in SEER lung cancer registries
Figure 13. Age effects on lung cancer mortality in SEER registries.
Figure 14. The age effects on lung cancer mortality in SEER lung cancer registries.
Figure 15. The period effects on the lung cancer mortality in SEER lung cancer registries.
Figure 16. The period effects on lung cancer mortality in SEER cancer registries.
Figure 17. The crude cohort effects on the lung cancer mortality in SEER lung cancer registries.
Figure 18. The cohort effects on the lung cancer mortality in SEER lung cancer registries.
Figure 19. The crude age effects on lung cancer mortality in the U.S.
Figure 20. Age effects on lung cancer mortality in the U.S
Figure 21. The crude period effects on lung cancer mortality in the U.S
Figure 22. The period effects on the lung cancer mortality in the U.S
Figure 23. The crude cohort effects on the lung cancer mortality in the U.S.
Figure 24. The cohort effects on the lung cancer mortality in the U.S
3. Model comparison.
The F test is used in the analysis to analyze age, period and cohort effects by
model comparison. According to the outputs, all three temporal effects are significant
in lung cancer incidence and mortality (Table.1, Table.2 and Table.3).
Table.1 Model comparison for SEER lung cancer incidence
Model Deviance Scaled
Deviance
Df A P C F-test P
All sex
Full
model
2144.6638 1918.9191 1920 Yes Yes Yes N/A N/A
Model 1 46035.7341 2207.5862 1968 No Yes Yes 914.4 <0.0001
Model 2 2430.4462 1961.0141 1960 Yes No Yes 7.1 <0.0001
Model 3 19247.9222 1977.0033 2009 Yes Yes No 192.2 <0.0001
Male
Full
model
2145.828 1926.2518 1920 Yes Yes Yes N/A N/A
Model 1 15976.3404 2187.3958 1968 No Yes Yes 288.1 <0.0001
Model 2 2575.2981 1976.0183 1960 Yes No Yes 10.7 <0.0001
Model 3 13039.7561 1945.9164 2009 Yes Yes No 122.4 <0.0001
Female
Full
model
2100.9995 1920.4648 1920 Yes Yes Yes N/A N/A
Model 1 28462.9274 2213.8054 1968 No Yes Yes 549.2 <0.0001
Model 2 2410.76 1960.9015 1960 Yes No Yes 7.7 <0.0001
Model 3 8539.2543 1985.2316 2009 Yes Yes No 72.3 <0.0001
Note: A, P and C in the table above represents the presence of age, period and cohort
effects.
Table.2 Model comparison for SEER lung cancer mortality
Model Deviance Scaled Deviance Df A P C F-test P
All sex
Full model 2088.8285 1920.4152 1920 Yes Yes Yes N/A N/A
Model 1 32456.8256 2209.6821 1968 No Yes Yes 632.7 <0.0001
Model 2 3906.3292 1999.3743 1960 Yes No Yes 45.4 <0.0001
Model 3 11789.0553 1978.7592 2009 Yes Yes No 109.0 <0.0001
Female
Full model 2023.049 1931.806 1920 Yes Yes Yes N/A N/A
Model 1 10179.1812 2180.9569 1968 No Yes Yes 170.0 <0.0001
Model 2 3592.6792 1998.5743 1960 Yes No Yes 39.2 <0.0001
Model 3 9038.3692 1952.9466 2009 Yes Yes No 78.8 <0.0001
Male
Full model 2011.8698 1920.1052 1920 Yes Yes Yes N/A N/A
Model 1 22171.9082 2218.4874 1968 No Yes Yes 420.0 <0.0001
Model 2 3070.1139 1979.7888 1960 Yes No Yes 26.5 <0.0001
Model 3 5143.5159 1996.9795 2009 Yes Yes No 35.2 <0.0001
Note: A, P and C in the table above represents the presence of age, period and cohort
effects.
Table.3 Model comparison for U.S lung cancer mortality
Model Deviance Scaled Deviance Df A P C F-test P
All sex
Full model 2079.7235 1921.4562 1920 Yes Yes Yes N/A N/A
Model 1 29664.994 2217.19 1968 No Yes Yes 574.7 <0.0001
Model 2 4433.1915 2018.2971 1960 Yes No Yes 58.8 <0.0001
Model 3 11789.0553 1982.4251 2009 Yes Yes No 109.3 <0.0001
Female
Full model 3003.1299 1907.6287 1920 Yes Yes Yes N/A N/A
Model 1 94916.3879 2213.8336 1968 No Yes Yes 1914.9 <0.0001
Model 2 11347.5737 1989.6678 1960 Yes No Yes 208.6 <0.0001
Model 3 80130.9023 1931.6032 2009 Yes Yes No 866.6 <0.0001
Male
Full model 2772.4528 1915.1487 1920 Yes Yes Yes N/A N/A
Model 1 202647.1553 2226.6305 1968 No Yes Yes 4164.1 <0.0001
Model 2 7532.8773 1965.9661 1960 Yes No Yes 119.0 <0.0001
Model 3 56445.0405 1990.7468 2009 Yes Yes No 603.1 <0.0001
Note: A, P and C in the table above represents the presence of age, period and cohort
effects.
Discussion:
For the overall lung cancer mortality trend, it is noticeable that mortality
increased with higher age. Meanwhile, there is slight increase for overall and female
lung cancer mortality by period. For cohort, we observe that the lung cancer mortality
peaks around 1920-1930, and the overall trend is decreasing by cohort.
The age effects on lung cancer incidence and mortality are consistent regardless
the target population and sex, which is biologically plausible because there is
age-dependent decline in the immunity for cancer in the aged. People with higher age
becomes more susceptible to cancer, which results in higher risk of lung cancer
compare to young people[3]. In addition, the median age of patients who have lung
cancer recurrence after treatment is around 69 years [4]. Another issue is that there
might be a potential gap in knowledge translation because aged patients were shown
less likely to refer and accept lung cancer treatment, which are frequently reported in
Canada. All these factors potentially contribute to the association between age and
lung cancer incidence and mortality[5].
For period and cohort effects on lung cancer incidence and mortality, the
mechanisms are more related to the cigarette distribution, smoking policy and relevant
intervention in the American history.
By looking at the period effects, the overall lung cancer mortality trends are relatively
constant, but females show increasing lung cancer mortality from 1973 to 2014. The
smoking data in the U.S suggest that the smoking rates in males dropped by 23.6%
from 1970 to 2013, while the dropping 16.2% in females, which might explain the
reason why we observed obvious decreasing tendency in male lung cancer mortality
but not female[6]. In detail, there is common concave down in period effects between
1980 and 1995, suggesting improvements in lung cancer mortality and incidence after
1995.
The period effects could be related to the smoking ban in the U.S, while the
difference in period effects between SEER and U.S may come from the different time
point regarding to the smoking ban. For example, California enacted a statewide
smoking ban in 1995[7] while the Alaska banned the statewide smoking in 2018[8].
On the other hand, lung cancer screening was introduced and became widely
processed in the United States. In the late 1990s, the first trial of low dose computed
Tomography on lung cancer screening was completed in the United States by the
Early Lung cancer, which more malignant and benign nodule were detected. Later,
positron emission tomography (PET) and fluorodeoxyglucose (FDG) were introduced
in 2003 and generated more promising results in lung cancer screening[9]. These
screening technologies help people detect the lung cancer earlier and drive the
negative departure in lung cancer mortality trends by period.
For cohort effects, there are also common concave down observed for lung cancer
incidence and mortality in SEER and the U.S except those effects in female. This
overall concave shape occurs between 1900 and 1940, suggesting an overall
improvement in lung cancer incidence and mortality after 1940. For the cohort effects
in female, the cohort effect reaches peaks around 1940 and 1960, then they declined
after 1960. In the smoking history in the U.S, cigarette smoking grew dramatically in
the early parts of the 20th century. The aggressive advertisement, automatic cigarette
rolling machine invention and promotion contributed the wide cigarette distribution
[10]. On the other hand, cigarette smoking increased rapidly in the U.S military
during the World War I in 1918, when cigarette could help soldiers psychologically
escape from the circumstances of war and boost the troop morale, according to the
tobacco companies at that time. Then, tobacco companies stimulated the wartime
smoking culture continuously during World War II [11][12][13]. The dynamics of
cohort curvature effects on female is a little bit different from these effects on males
and the overall population. In 1920s, the suffrage movement in the U.S made many
women learn a sense of entitlement and freedom. During that period, tobacco
companies took advantage of the suffrage movement and targeted women by
aggressive advertisement, which convinced them that smoking cigarette was an
effective way for showing their freedom and entitlement. These tobacco companies
even encouraged women smoke instead of eating candies and exaggerated the benefits
of cigarette[14]. Then in 1950s and 1960s, the smoking rate in women increased
rapidly under the impact of TV show and advertisement, which was much more than
the previous cigarette marketing strategy for women in the U.S. It was reported that
around 33.9% women smoked in 1965. The history of women smoking between
1920s and 1960s explains the two peaks around 1940 and 1960. In 1970s and health
warnings about the dangers of smoking began to be print on the advertisement and
annual reports of health consequence of smoking was reported. In 1980s, the first
Surgeon General's Report on the Health Consequences of Smoking for Women was
carried out, and the smoking rate in women dropped to 29.3%[15].The smoking
history event in 1970s and 1980s explains the cohort effects change into negative
departure in the lung cancer mortality trend by cohort.
Conclusion:
The age, period and cohort effects are significant on the lung cancer mortality and
incidence. Historic events of interest including lung cancer screening and tobacco
selling are strongly associated with these curvature changes in the lung cancer
incidence trend and mortality trend. The study of age, period and cohort effects is
helpful for evaluating public health interventions on cancer and predicting the
outcomes the future lung cancer trend of those interventions. Because our research
belongs to the field of cancer surveillance in the U.S, the lung cancer modeling in this
paper provides an overview of the lung cancer patterns under the temporal effects in
U.S. This pattern analysis will be helpful for evaluating the impacts of health policy,
healthcare innovation, technology improvement and historic events on the lung cancer
incidence and mortality at population level. Besides, the identifiability problems in
the APC model due to the collinearity and unequal intervals are solved by analyzing
the curvature effects and the application of smoothing spline function, which provides
better estimate of these temporal effects. One limitation is that we didn’t analyze the
potential interaction between age, period and cohort, which should be the future
research direction.
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